Again, maybe NGIO has $300MM+ potential, but until
Post# of 36537
Don't get me wrong, I think there is value there. However, this kind of valuation hinges on someone seeing a payday in the near future. Might need Phase II results?
Dunno, I'm not an expert on drug companies... will be pleasantly and jubilantly surprised if Joe is able to attain that sort of $!